Summary & Overview
CPT 52597: Robotic Waterjet Prostate Tissue Removal
CPT code 52597 identifies a minimally invasive, robot-assisted procedure that removes prostate tissue using high-pressure waterjets delivered through the urethra, with required planning, ultrasound guidance, and bleeding control. This technique represents an emerging surgical approach for obstructive prostatic disease and tissue debulking that can affect outpatient surgical volumes and device utilization nationally. Payers covered in this summary include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The report gives readers a concise clinical and billing orientation to the procedure: its service type and typical sites of service, common bundled intraoperative elements, and what payers commonly address in coverage and coding review. Readers will find benchmarks and comparators for utilization and reimbursement where available, summaries of payer policy approaches and coding guidance, and clinical context about indications and settings in which the procedure is performed. Data not available in the input is noted where applicable. The focus is national in scope and aims to inform coding, billing, and policy stakeholders about how CPT code 52597 is described and positioned within minimally invasive prostatic procedures.
Billing Code Overview
CPT code 52597 describes a procedure in which the provider uses robotic assistance to remove prostate tissue with high–pressure waterjets delivered through the urethra. The service includes procedure planning, ultrasound guidance, and intraoperative steps to control bleeding. Included ancillary procedures such as vasectomy, meatotomy, cystourethroscopy, urethral calibration or dilation, and internal urethrotomy are part of the service when performed.
Service type: Minimally invasive prostatic tissue ablation/removal using robotic waterjet technology
Typical site of service: Ambulatory surgical center or hospital operating room, with intraoperative ultrasound guidance and cystourethroscopy as needed.
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with symptomatic benign prostatic hyperplasia (BPH) presents with lower urinary tract symptoms (LUTS) including urinary frequency, nocturia, weak stream, and incomplete emptying refractory to medical therapy (alpha-blockers and 5-alpha-reductase inhibitors). After evaluation with history, physical exam including digital rectal exam, urinalysis, serum PSA, and transrectal or transabdominal ultrasound to estimate prostate volume, the urologist recommends a waterjet enucleation of prostate tissue using robotic assistance (52597) to relieve obstruction.
The clinical workflow includes pre-procedure counseling and consent, preoperative labs and anesthesia assessment, intraoperative planning and ultrasound guidance to localize adenomatous tissue, robotic-assisted delivery of high-pressure waterjets transurethrally to enucleate obstructing tissue, concurrent cystourethroscopy to monitor the urethra and bladder, control of bleeding (hemostasis measures), retrieval of tissue fragments or evacuation, and placement of a urinary catheter for postoperative drainage. Postoperative care includes monitoring for bleeding, urinary retention, infection, catheter management, and follow-up to assess symptom improvement and pathology results if tissue was sent for analysis.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component |